First Trust NYSE Arca Biotechnology Index Fund Rating $159.31 -1.15 (-0.72%) As of 10:09 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.69Holdings in FBT have an aggregate rating of Moderate Buy based on 535 analyst ratings issued in the past year covering 30 companies (95.2% of the portfolio).FBT Aggregate Price Target$158.26-0.66% DownsideHigh Prediction$158.26Average Prediction$158.26Low Prediction$158.26Holdings in FBT have an aggregate price target of $158.26 and a range of $158.26 to $158.26 covering 30 companies (95.2% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.35%CORTCorcept Therapeutics$70.53-1.8%4.5028 of 5 stars3.00$143.25 103.1%5Upcoming EarningsPositive News5.03%ONCBeigene$248.16-3.1%2.2918 of 5 stars3.00$318.88 28.5%5Analyst ForecastNews Coverage4.77%KRYSKrystal Biotech$167.09-1.2%4.7583 of 5 stars3.00$220.00 31.7%8News CoveragePositive News4.20%GILDGilead Sciences$102.89-3.1%4.5614 of 5 stars2.79$108.50 5.5%28Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsGap Down3.97%VRTXVertex Pharmaceuticals$490.07-0.5%4.028 of 5 stars2.64$514.91 5.1%25Analyst ForecastAnalyst RevisionPositive News3.97%AMGNAmgen$279.38-0.2%4.6571 of 5 stars2.43$310.57 11.2%23Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News3.94%HALOHalozyme Therapeutics$59.22-0.1%4.41 of 5 stars2.60$62.89 6.2%10News Coverage3.79%ALKSAlkermes$27.76+0.3%4.7926 of 5 stars2.67$38.50 38.7%12Upcoming EarningsNews CoveragePositive News3.70%ALNYAlnylam Pharmaceuticals$250.25+3.1%4.6078 of 5 stars2.77$315.58 26.1%26Upcoming EarningsAnalyst UpgradePositive News3.42%EXELExelixis$37.11-0.3%4.3047 of 5 stars2.50$37.59 1.3%20Upcoming EarningsPositive News3.37%BMRNBioMarin Pharmaceutical$62.80+0.1%4.8884 of 5 stars2.71$94.00 49.7%24Upcoming Earnings3.14%ACADACADIA Pharmaceuticals$14.64-1.3%4.0539 of 5 stars2.50$23.93 63.5%16Positive News3.05%WATWaters$336.09-1.4%4.0407 of 5 stars2.61$392.13 16.7%18Analyst Forecast3.04%MTDMettler-Toledo International$1,061.76-1.2%3.5282 of 5 stars2.22$1,304.25 22.8%9Upcoming EarningsAnalyst ForecastNews CoveragePositive News3.02%ARGXargenx$605.61+0.8%3.4815 of 5 stars2.91$699.28 15.5%23News CoveragePositive News2.98%INCYIncyte$58.71-0.4%4.8428 of 5 stars2.21$74.69 27.2%19Upcoming Earnings2.95%REGNRegeneron Pharmaceuticals$593.65-1.0%4.7959 of 5 stars2.88$945.32 59.2%26Upcoming EarningsAnalyst ForecastAnalyst Revision2.95%BIIBBiogen$118.81-0.6%4.7695 of 5 stars2.42$211.37 77.9%31Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage2.92%GMABGenmab A/S$20.60+0.3%4.2383 of 5 stars2.69$39.17 90.2%13Analyst Revision2.83%UTHRUnited Therapeutics$291.55-1.6%4.9244 of 5 stars2.67$390.17 33.8%12Upcoming EarningsInsider TradePositive News2.66%NTRANatera$153.06-0.9%2.9771 of 5 stars3.00$175.76 14.8%16Insider TradeNews CoveragePositive News2.64%RGENRepligen$143.78-1.0%4.5559 of 5 stars2.57$176.82 23.0%14Upcoming EarningsNews Coverage2.63%EXASExact Sciences$45.42-0.4%4.2736 of 5 stars2.95$69.25 52.5%22Upcoming EarningsAnalyst RevisionNews Coverage2.52%BNTXBioNTech$117.82-2.3%1.6472 of 5 stars2.89$143.44 21.7%18Analyst Revision2.45%NBIXNeurocrine Biosciences$106.41+0.6%4.8243 of 5 stars2.86$161.14 51.4%22Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage2.30%VCYTVeracyte$32.130.0%3.99 of 5 stars2.70$42.60 32.6%10Analyst RevisionNews Coverage2.08%BRKRBruker$38.90-0.2%4.8765 of 5 stars2.55$65.00 67.1%11Positive News2.05%MRNAModerna$27.65+1.0%4.3561 of 5 stars2.04$58.70 112.3%24Upcoming EarningsGap Down1.88%ILMNIllumina$76.50-1.4%4.6267 of 5 stars2.48$138.70 81.3%211.58%SRPTSarepta Therapeutics$61.34-0.7%4.6692 of 5 stars2.83$158.70 158.7%24 This page (NYSEARCA:FBT) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FBT Stock Free FBT Stock Alerts